Capital Rx acquires Amino Health

Capital Rx & Amino Health: New Pharmacy Benefits Leader

Healthcare Navigation Gets a Boost: Capital Rx Acquires Amino Health The healthcare landscape is shifting. Access to clear, affordable care is a major concern for many. Recently, Capital Rx finalized the acquisition of Amino Health. This move aims to simplify how people find and access the care they need. It also focuses on making costs […]

Read More →
Exclusive: Pangea Data, AstraZeneca's Alexion partner to spot rare disease with EHRs

Rare Disease Detection: AI & Health Records Team Up.

AI Aims to Speed Up Diagnosis of Rare Bone Disorder A new partnership is focusing on improving how quickly a rare genetic condition is identified. The collaboration will use artificial intelligence (AI) to analyze patient data and flag potential cases of hypophosphatasia. This condition impacts bone development and can cause significant health problems. Early detection […]

Read More →
Why do you crave sugar? It might be genetic

Sugar Cravings: Is It In Your Genes?

The Sugar Code: Why Your Cravings Might Be in Your Genes We all know the feeling. That insistent pull towards something sweet. A soda, a cookie, a chocolate bar… But what if that desire isn’t just a momentary weakness? Emerging research suggests your genetic makeup might play a bigger role in your sugar cravings than […]

Read More →
Omada Health debuts on Nasdaq at $19 per share

Omada Health IPO: Stock Opens at $19

Digital Health Company Set to Begin Trading on Nasdaq A leading chronic care management firm is making its debut on the Nasdaq Global Market tomorrow, June 6th, under the ticker symbol OMDA. Shares are priced at $19 each, falling in the middle of the projected range. The initial public offering (IPO) is expected to generate […]

Read More →